Companies: 10,795·Total market cap: $144.5T
OptiBiotix Health Plc

OptiBiotix Health Plc

OPBXFOTCHealthcare
$0.22
+$0.00(+0.00%)
Market Cap$20061955
P/E Ratio
52W High$0.22
52W Low$0.22

OptiBiotix Health Plc (OPBXF) Revenue

Annual & quarterly revenue history · segment & region breakdown

OPBXF · revenue · updated Jun 8, 2026

Core revenue metrics

OptiBiotix Health Plc trailing twelve-month (TTM) revenue is $0.00B, a decrease of 79.35% year-over-year from $0.00B in FY2022.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
-79.35%
vs FY2022 $0.00B
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
9 employees
FY2022
$0.00B
FY2021
$0.00B
5Y CAGR
+19.1%
Fiscal year end
Dec 31
Currency
GBP · GAAP
Filing
10-K / 10-Q
Source: FMP · OptiBiotix Health Plc SEC filings · GAAPUpdated: 2026-06-08

Revenue trend

20222008 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2022-12-31$0.00B-$0.00B-79.35%
2021-12-31$0.00B+$0.00B+45.28%
2020-12-31$0.00B+$0.00B+196.19%
2018-11-30$0.00B+$0.00B+169.16%
2017-11-30$0.00B-$0.00B-33.68%
2016-11-30$0.00B+$0.00B+921.70%
2015-11-30$0.00B+$0.00B
2014-11-30$0.00B-$0.00B-100.00%
2012-07-31$0.00B+$0.00B
2010-07-31$0.00B+$0.00B
OPBXF revenue by year · OPBXF revenue history · OPBXF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income OptiBiotix Health Plc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

OptiBiotix Health Plc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in GBP.

Data sourced from OptiBiotix Health Plc's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

OPBXF revenue · 4 questions

OPBXF's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 79.35% year-over-year from $0.00B in FY2022.

OPBXF revenueOPBXF annual revenuewhat is OPBXF revenueOPBXF TTM revenue

Source: FMP · OptiBiotix Health Plc SEC filings · GAAP · OptiBiotix Health Plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026